The COMFORT Trial: A randomised control trial comparing group-based COMpassion FOcused Therapy and breathing pattern ReTraining with Treatment As Usual on the psychological functioning of patients diagnosed with cancer recurrence during COVID.

Author:

Lynch Sinead1,Lowry Damien1ORCID,Finnerty Clodagh2,O'Meara Yvonne2,Brennan Donal1

Affiliation:

1. Mater Misericordiae University Hospital

2. University College Dublin School of Medicine

Abstract

AbstractBackground A cancer diagnosis is a known precipitant of psychological distress, with fear of recurrence being a well-documented distressing consequence of cancer. Cancer recurrence often results in an additional psychological burden, which may exacerbated as a result of the COVID-19 pandemic. Methods This is a single-centre, prospective, randomised controlled trial. Patients identified as having experienced cancer recurrence since March 2020 (the onset of COVID-19 pandemic in Ireland) will be screened for participation. Eligible, consenting candidates who score 4 or higher on the Distress Thermometer will be enrolled into the study. Participants will be randomly allocated to receive either a 6-week, group-based, online, Compassion Focussed Therapy and Breathing Pattern Retraining intervention or the control arm. Those in the control arm will all be offered the group intervention after the 18-week study period. The primary outcome is the Distress Thermometer score at 18-weeks post-baseline though secondary outcomes will include measures of mood, traumatic distress and mental adjustment to cancer. Discussion To our knowledge, this protocol describes the first RCT which directly examines the effect of a group-based psychological intervention on Irish patients experiencing cancer recurrence in the context of COVID-19. The outcome of this trial is likely to be twofold: It will determine if the psychological intervention achieves its primary objective of distress amelioration three months post-intervention; and to establish the feasibility of delivering this intervention in a virtual format. Trial registration Trial registration: ClinicalTrials.gov NCT05518591. Registered on 25 August 2022. All items from the World Health Organisation Trial Registration Data set have been included.

Publisher

Research Square Platform LLC

Reference33 articles.

1. National Cancer Registry Ireland. (2016a). Cancer factsheet: Statistics. Retrieved from: http://www.ncri.ie/data/survival-statistics.

2. Seasons of survival: Reflections of a physician with cancer;Mullan F;N Engl J Med,1985

3. Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance;Nilsson R;Eur Urol Open Sci,2021

4. Fear of cancer recurrence or progression: what is it and what can we do about it? American Society of Clinical Oncology Educational Book;Bergerot CD,2022

5. Fear of disease progression and psychological stress in cancer patients under the outbreak of COVID-19;Chen G;Psychooncology,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3